Expertise in
8
conditions

Sema K. Ucar

Ege, TR 
Expertise in
8
conditions
Ege, TR 

Overview

Sema Ucar practices practicing medicine in Ege, Turkey.

Ms. Ucar is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Mitochondrial Neurogastrointestinal Encephalopathy Disease, Carnitine Palmitoyltransferase 2 Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, and Von Gierke Disease.

She is actively involved in clinical research, co-authoring 46 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Ege, 35100, Turkey
Other Locations
Bornova, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Biological
Study Drugs: PRX-102 (Pegunigalsidase Alfa), Agalsidase Beta
Study Phase: Phase 3
Natural History Study of Mitochondrial Neurogastrointestinal Encephalomyopathy
Natural History Study of Mitochondrial Neurogastrointestinal Encephalomyopathy
Enrollment Status: Suspended
Publish Date: July 22, 2021
Intervention Type: Other
View 1 Less Clinical Trial

46 Total Publications

Harmonizing Perspectives on MPS II Care in Türkiye: A Delphi Study Towards Treatment Management Consensus.
Harmonizing Perspectives on MPS II Care in Türkiye: A Delphi Study Towards Treatment Management Consensus.
Journal: Healthcare (Basel, Switzerland)
Published: February 20, 2026

Frequently Asked Questions about Sema K. Ucar

Is Sema K. Ucar a top-rated expert for Mitochondrial Neurogastrointestinal Encephalopathy Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Sema K. Ucar is classified as an Distinguished expert for Mitochondrial Neurogastrointestinal Encephalopathy Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sema K. Ucar participate in research or clinical trials?

Yes. Sema K. Ucar has published 46 articles and abstracts on conditions like Mitochondrial Neurogastrointestinal Encephalopathy Disease. You can view a list of Sema K. Ucar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ucar's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 41 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile